Chemomab Therapeutics CMMB reported its Q2 earnings results on Friday, August 12, 2022 at 06:00 AM.
Here’s what investors need to know about the announcement.
Chemomab Therapeutics missed estimated earnings by 116.0%, reporting an EPS of $-0.54 versus an estimate of $-0.25.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.22 which was followed by a 8.14% increase in the share price the next day.
To track all earnings releases for Chemomab Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.